Filed: 2/17/2026ACC: 0001615982-26-000005
📋 What this filing means
VENROCK ADVISER, LLC filed this quarterly 13F‑HR report disclosing 27 equity positions with a total reported market value of $2.02B. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
27
Positions
$2.02B
Total AUM (reported)
124.68M
Total Shares
Allocation by class
COM$1.75B86.6%
COM NEW$241.57M11.9%
CLASS A ORD SHS$28.01M1.4%
ORD SHS$839.2K0.0%
Portfolio Concentration
Top 3$887.64M43.8%
4–10$604.83M29.9%
11–25$524.30M25.9%
Rest$7.74M0.4%
Top 3 weight
43.8%
Top 10 weight
73.7%
Voting Authority Distribution
Total shares with voting rights: 124.68M
Sole
Full voting authority
124.68M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole27
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings27
Rows:
APOGEE THERAPEUTICS INC
SOLEShares8.49M
TypeSH
Market value$641.08M
31.67%
Sole
8.49M
Shared
0.00
None
0.00
ORUKA THERAPEUTICS INC
SOLEShares4.15M
TypeSH
Market value$125.74M
6.21%
Sole
4.15M
Shared
0.00
None
0.00
VIRIDIAN THERAPEUTICS INC
SOLEShares3.88M
TypeSH
Market value$120.83M
5.97%
Sole
3.88M
Shared
0.00
None
0.00
SPYRE THERAPEUTICS INC
SOLEShares3.69M
TypeSH
Market value$120.74M
5.96%
Sole
3.69M
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares6.73M
TypeSH
Market value$108.67M
5.37%
Sole
6.73M
Shared
0.00
None
0.00
OCULAR THERAPEUTIX INC
SOLEShares7.32M
TypeSH
Market value$88.81M
4.39%
Sole
7.32M
Shared
0.00
None
0.00
SAVARA INC
SOLEShares13.74M
TypeSH
Market value$82.85M
4.09%
Sole
13.74M
Shared
0.00
None
0.00
COGENT BIOSCIENCES INC
SOLEShares2M
TypeSH
Market value$71.04M
3.51%
Sole
2M
Shared
0.00
None
0.00
ERASCA INC
SOLEShares17.86M
TypeSH
Market value$66.43M
3.28%
Sole
17.86M
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares15.56M
TypeSH
Market value$66.29M
3.27%
Sole
15.56M
Shared
0.00
None
0.00
MAZE THERAPEUTICS INC
SOLEShares1.55M
TypeSH
Market value$64.16M
3.17%
Sole
1.55M
Shared
0.00
None
0.00
JADE BIOSCIENCES INC
SOLEShares3.22M
TypeSH
Market value$49.69M
2.45%
Sole
3.22M
Shared
0.00
None
0.00
ENLIVEN THERAPEUTICS INC
SOLEShares3.23M
TypeSH
Market value$49.69M
2.45%
Sole
3.23M
Shared
0.00
None
0.00
ORIC PHARMACEUTICALS INC
SOLEShares5.68M
TypeSH
Market value$46.43M
2.29%
Sole
5.68M
Shared
0.00
None
0.00
ENGENE HOLDINGS INC
SOLEShares4.77M
TypeSH
Market value$43.09M
2.13%
Sole
4.77M
Shared
0.00
None
0.00
DYNE THERAPEUTICS INC
SOLEShares2.17M
TypeSH
Market value$42.52M
2.10%
Sole
2.17M
Shared
0.00
None
0.00
DIANTHUS THERAPEUTICS INC
SOLEShares1M
TypeSH
Market value$41.21M
2.04%
Sole
1M
Shared
0.00
None
0.00
UPSTREAM BIO INC
SOLEShares1.17M
TypeSH
Market value$31.75M
1.57%
Sole
1.17M
Shared
0.00
None
0.00
CYBIN INC
SOLEShares3.84M
TypeSH
Market value$31.41M
1.55%
Sole
3.84M
Shared
0.00
None
0.00
ZURA BIO LTD
SOLEShares5.35M
TypeSH
Market value$28.01M
1.38%
Sole
5.35M
Shared
0.00
None
0.00
VOR BIOPHARMA INC
SOLEShares1.94M
TypeSH
Market value$25.42M
1.26%
Sole
1.94M
Shared
0.00
None
0.00
CRESCENT BIOPHARMA INC.
SOLEShares2.13M
TypeSH
Market value$25.30M
1.25%
Sole
2.13M
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares610.81K
TypeSH
Market value$17.03M
0.84%
Sole
610.81K
Shared
0.00
None
0.00
SURROZEN INC
SOLEShares632.93K
TypeSH
Market value$14.30M
0.71%
Sole
632.93K
Shared
0.00
None
0.00
CULLINAN THERAPEUTICS INC
SOLEShares1.38M
TypeSH
Market value$14.28M
0.71%
Sole
1.38M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
APOGEE THERAPEUTICS INCSOLE | COM | 8.49M | SH | $641.08M 31.67% | 8.49M | 0.00 | 0.00 |
ORUKA THERAPEUTICS INCSOLE | COM | 4.15M | SH | $125.74M 6.21% | 4.15M | 0.00 | 0.00 |
VIRIDIAN THERAPEUTICS INCSOLE | COM | 3.88M | SH | $120.83M 5.97% | 3.88M | 0.00 | 0.00 |
SPYRE THERAPEUTICS INCSOLE | COM NEW | 3.69M | SH | $120.74M 5.96% | 3.69M | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 6.73M | SH | $108.67M 5.37% | 6.73M | 0.00 | 0.00 |
OCULAR THERAPEUTIX INCSOLE | COM | 7.32M | SH | $88.81M 4.39% | 7.32M | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 13.74M | SH | $82.85M 4.09% | 13.74M | 0.00 | 0.00 |
COGENT BIOSCIENCES INCSOLE | COM | 2M | SH | $71.04M 3.51% | 2M | 0.00 | 0.00 |
ERASCA INCSOLE | COM | 17.86M | SH | $66.43M 3.28% | 17.86M | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 15.56M | SH | $66.29M 3.27% | 15.56M | 0.00 | 0.00 |
MAZE THERAPEUTICS INCSOLE | COM | 1.55M | SH | $64.16M 3.17% | 1.55M | 0.00 | 0.00 |
JADE BIOSCIENCES INCSOLE | COM NEW | 3.22M | SH | $49.69M 2.45% | 3.22M | 0.00 | 0.00 |
ENLIVEN THERAPEUTICS INCSOLE | COM | 3.23M | SH | $49.69M 2.45% | 3.23M | 0.00 | 0.00 |
ORIC PHARMACEUTICALS INCSOLE | COM | 5.68M | SH | $46.43M 2.29% | 5.68M | 0.00 | 0.00 |
ENGENE HOLDINGS INCSOLE | COM | 4.77M | SH | $43.09M 2.13% | 4.77M | 0.00 | 0.00 |
DYNE THERAPEUTICS INCSOLE | COM | 2.17M | SH | $42.52M 2.10% | 2.17M | 0.00 | 0.00 |
DIANTHUS THERAPEUTICS INCSOLE | COM | 1M | SH | $41.21M 2.04% | 1M | 0.00 | 0.00 |
UPSTREAM BIO INCSOLE | COM | 1.17M | SH | $31.75M 1.57% | 1.17M | 0.00 | 0.00 |
CYBIN INCSOLE | COM NEW | 3.84M | SH | $31.41M 1.55% | 3.84M | 0.00 | 0.00 |
ZURA BIO LTDSOLE | CLASS A ORD SHS | 5.35M | SH | $28.01M 1.38% | 5.35M | 0.00 | 0.00 |
VOR BIOPHARMA INCSOLE | COM NEW | 1.94M | SH | $25.42M 1.26% | 1.94M | 0.00 | 0.00 |
CRESCENT BIOPHARMA INC.SOLE | COM | 2.13M | SH | $25.30M 1.25% | 2.13M | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 610.81K | SH | $17.03M 0.84% | 610.81K | 0.00 | 0.00 |
SURROZEN INCSOLE | COM NEW | 632.93K | SH | $14.30M 0.71% | 632.93K | 0.00 | 0.00 |
CULLINAN THERAPEUTICS INCSOLE | COM | 1.38M | SH | $14.28M 0.71% | 1.38M | 0.00 | 0.00 |
Page 1 of 2